Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tenet Healthcare (THC)
NYSE:THC
Holding THC?
Track your performance easily
THC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$51.04 - $166.89
Previous Close$162.41
Volume874.44K
Average Volume (3M)1.19M
Market Cap
$15.77B
Enterprise Value$29.95B
Total Cash (Recent Filing)$2.88B
Total Debt (Recent Filing)$12.87B
Price to Earnings (P/E)5.9
Beta1.22
Next Earnings
Oct 17, 2024EPS Estimate
$2.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)27.33
Shares Outstanding95,822,000
10 Day Avg. Volume1,174,504
30 Day Avg. Volume1,194,289
Standard Deviation0.16
R-Squared0.48
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.54
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)5.20
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.86
Enterprise Value/Gross Profit1.77
Enterprise Value/Ebitda22.32
Forecast
1Y Price Target
$168.80Price Target Upside2.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Tenet Healthcare News
PremiumCompany Announcements
Tenet Healthcare Announces Major Sale and New Contract
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTHC reported strong Q2:24 results, with adjusted EBITDA of $945mm (+12.1% y/y) beating our and consensus estimates by +9% and +8%, respectively.
Shareholder ReturnsTHC bought back another $270m of stock, announced a new $1.5b repo program which elevates the emerging and under-appreciated investment case for industry-leading 20%+ EPS growth over a multi-year cycle.
Strategic Business RebalancingTHC's sale of its B-ham market once again illustrates the company's desires to reinvest capital into its faster growing, higher margin, higher return ambulatory platform while balancing with deleveraging opportunities.
Bears Say
Financial PerformanceAnchoring in assumptions on almost no sequential EBITDA growth at USPI would imply around a 16-17% decline sequentially in the Acute/Conifer segment after adjusting 1Q for non-recurring factors.
Historical PerformanceIt has a long track record with investors over decades as underperforming.
Market GrowthIts hospitals typically grow at a lower pace vs others due to their markets and lack of MCO negotiating power.
---
Ownership Overview
17.35% Insiders
26.90% Mutual Funds
46.24% Other Institutional Investors
9.50% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
THC FAQ
What was Tenet Healthcare’s price range in the past 12 months?
Tenet Healthcare lowest stock price was $51.04 and its highest was $166.89 in the past 12 months.
What is Tenet Healthcare’s market cap?
Currently, no data Available
When is Tenet Healthcare’s upcoming earnings report date?
Tenet Healthcare’s upcoming earnings report date is Oct 17, 2024 which is in 29 days.
How were Tenet Healthcare’s earnings last quarter?
Tenet Healthcare released its earnings results on Jul 24, 2024. The company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $1.897 by $0.413.
Is Tenet Healthcare overvalued?
According to Wall Street analysts Tenet Healthcare’s price is currently Undervalued.
Does Tenet Healthcare pay dividends?
Tenet Healthcare does not currently pay dividends.
What is Tenet Healthcare’s EPS estimate?
Tenet Healthcare’s EPS estimate is $2.31.
How many shares outstanding does Tenet Healthcare have?
Tenet Healthcare has 95,822,000 shares outstanding.
What happened to Tenet Healthcare’s price movement after its last earnings report?
Tenet Healthcare reported an EPS of $2.31 in its last earnings report, beating expectations of $1.897. Following the earnings report the stock price went up 4.802%.
Which hedge fund is a major shareholder of Tenet Healthcare?
Among the largest hedge funds holding Tenet Healthcare’s share is Glenview Capital Management LLC. It holds Tenet Healthcare’s shares valued at 621M.
---
Tenet Healthcare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$168.80 (2.54% Upside)
$168.80 (2.54% Upside)
Blogger Sentiment
Bullish
THC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $21.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.6%
Last 30 Days ▲ 14.1%
Last 30 Days ▲ 14.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
128.81%
12-Months-Change
Fundamentals
Return on Equity
114.36%
Trailing 12-Months
Asset Growth
7.76%
Trailing 12-Months
Company Description
Tenet Healthcare
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities. It operates through the following business segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans, and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.
---
THC Company Deck
---
THC Earnings Call
Q2 2024
0:00 / 0:00
---
THC Stock 12 Month Forecast
Average Price Target
$168.80
▲(2.54% Upside)
Technical Analysis
Best Analysts Covering THC
1 Year
1 Year Success Rate
14/16 ratings generated profit
1 Year Average Return
+47.37%
reiterated a buy rating last month
Copying David S Macdonald's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +47.37% per trade.
---